Biogen’s Leqembi iqlik autoinjector available in U.S. for early Alzheimer’s
Eisai and Biogen said the Leqembi iqlik (lecanemab-irmb) autoinjector is now available in the U.S. to initiate therapy for early Alzheimer’s disease.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.